Literature DB >> 15657267

Sequential pathology after experimental infection with marine viral hemorrhagic septicemia virus isolates of low and high virulence in turbot (Scophthalmus maximus L).

B E Brudeseth1, R S Raynard, J A King, O Evensen.   

Abstract

Three marine viral hemorrhagic septicemia virus isolates were used to bath challenge turbot with the purpose of studying mortality and the pathology and antigen distribution over time. Two high-virulence isolates, 860/94, 4p168 and a low-virulence isolate 1p3 from a Baltic Sea herring were used. Organ samples were collected sequentially at 2, 4, 7, 10, 15, 20, 25, and 45 days postinfection. Specimens were processed for virology, histopathology, and immunohistochemistry. Organs during the early stages of infection (from 2 to 7 days) had virus isolation from all three groups only on day 7. Virus titer in kidney and heart sampled at day 25 was higher for the two virulent isolates compared with the low-virulence isolate. The viral distribution in situ of the two more virulent isolates from turbot (860/94) and herring (4p168) resembled viral hemorrhagic septicemia in rainbow trout with regard to the target organs. Early infection of endothelial cells in both kidney and heart was observed. Accumulated mean mortality was 41.5% for the turbot isolate 860/94, 48% for the herring isolate 4p168, and 3.5% for the herring isolate 1p3. This study revealed that the isolates from turbot (860/94) and herring (4p168) induced significantly higher mortality compared with the virus-free control and the herring isolate (1p3). The onset of mortality is markedly later in turbot compared with what is seen in rainbow trout.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15657267     DOI: 10.1354/vp.42-1-9

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  7 in total

1.  Shedding of viral hemorrhagic septicemia virus (Genotype IVb) by experimentally infected muskellunge (Esox masquinongy).

Authors:  Robert K Kim; Mohamed Faisal
Journal:  J Microbiol       Date:  2012-04-27       Impact factor: 3.422

2.  Characterisation of a monoclonal antibody detecting Atlantic salmon endothelial and red blood cells, and its association with the infectious salmon anaemia virus cell receptor.

Authors:  Maria Aamelfot; Simon C Weli; Ole B Dale; Erling O Koppang; Knut Falk
Journal:  J Anat       Date:  2013-02-25       Impact factor: 2.610

3.  Tissue Distribution of the Piscine Novirhabdovirus Genotype IVb in Muskellunge (Esox masquinongy).

Authors:  Robert K Kim; Scott D Fitzgerald; Matti Kiupel; Mohamed Faisal
Journal:  Animals (Basel)       Date:  2022-06-24       Impact factor: 3.231

4.  Differences in virulence of marine and freshwater isolates of viral hemorrhagic septicemia virus in vivo correlate with in vitro ability to infect gill epithelial cells and macrophages of rainbow trout (Oncorhynchus mykiss).

Authors:  Bjørn E Brudeseth; Helle F Skall; Øystein Evensen
Journal:  J Virol       Date:  2008-08-27       Impact factor: 5.103

5.  Microarray-based identification of differentially expressed genes in families of turbot (Scophthalmus maximus) after infection with viral haemorrhagic septicaemia virus (VHSV).

Authors:  P Díaz-Rosales; A Romero; P Balseiro; S Dios; B Novoa; A Figueras
Journal:  Mar Biotechnol (NY)       Date:  2012-07-13       Impact factor: 3.619

6.  Characterization of a VHS virus genotype III isolated from rainbow trout (Oncorhychus mykiss) at a marine site on the west coast of Norway.

Authors:  Henrik Duesund; Stian Nylund; Kuninori Watanabe; Karl F Ottem; Are Nylund
Journal:  Virol J       Date:  2010-01-26       Impact factor: 4.099

7.  Susceptibility and Pathology in Juvenile Atlantic Cod Gadus morhua to a Marine Viral Haemorrhagic Septicaemia Virus Isolated from Diseased Rainbow Trout Oncorhynchus mykiss.

Authors:  Nina Sandlund; Renate Johansen; Ingrid U Fiksdal; Ann Cathrine B Einen; Ingebjørg Modahl; Britt Gjerset; Øivind Bergh
Journal:  Animals (Basel)       Date:  2021-12-10       Impact factor: 2.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.